Search Results - "Luczak, Michal W"

Refine Results
  1. 1
  2. 2

    Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors by Meyers, Lauren M., Krawic, Casey, Luczak, Michal W., Zhitkovich, Anatoly

    Published in Toxicology and applied pharmacology (15-06-2022)
    “…Transcription factors HIF1 and HIF2 are central regulators of physiological responses to hypoxia and important for normal functioning of tissue stem cells and…”
    Get full text
    Journal Article
  3. 3

    HMGB1 Carried by Small Extracellular Vesicles Potentially Plays a Role in Promoting Acquired Middle Ear Cholesteatoma by Łuczak, Michał W, Dżaman, Karolina, Zaręba, Łukasz, Czerwaty, Katarzyna, Siewiera, Jacek, Głuszko, Alicja, Olszewska, Ewa, Brzost, Jacek, Kantor, Ireneusz, Szczepański, Mirosław J, Ludwig, Nils

    Published in Diagnostics (Basel) (01-11-2023)
    “…Cholesteatoma is a specific medical condition involving the abnormal, non-cancerous growth of skin-like tissue in the middle ear, potentially leading to a…”
    Get full text
    Journal Article
  4. 4

    20S immunoproteasomes remove formaldehyde-damaged cytoplasmic proteins suppressing caspase-independent cell death by Ortega-Atienza, Sara, Krawic, Casey, Watts, Lauren, McCarthy, Caitlin, Luczak, Michal W., Zhitkovich, Anatoly

    Published in Scientific reports (05-04-2017)
    “…Immunoproteasomes are known for their involvement in antigen presentation. However, their broad tissue presence and other evidence are indicative of nonimmune…”
    Get full text
    Journal Article
  5. 5

    Sensitive Detection of Histones and γ‑H2AX by Immunoblotting: Problems and Solutions by Krawic, Casey, Luczak, Michal W., Zhitkovich, Anatoly

    Published in Chemical research in toxicology (16-09-2024)
    “…Histones and their posttranslational modifications (PTMs) are critical regulators of gene expression. Differentiation, environmental stressors, xenobiotics,…”
    Get full text
    Journal Article
  6. 6

    Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma by LUCZAK, Michał W, ROSZAK, Andrzej, PAWLIK, Piotr, KEDZIA, Helena, LIANERI, Margarita, JAGODZINSKI, Pawel P

    Published in Oncology reports (01-11-2011)
    “…The development of cervical cancer exhibits some unique differences compared to other solid tumors. Normal cervical stratified epithelia have characteristics…”
    Get full text
    Journal Article
  7. 7

    Monoubiquitinated γ-H2AX: Abundant product and specific biomarker for non-apoptotic DNA double-strand breaks by Luczak, Michal W., Zhitkovich, Anatoly

    Published in Toxicology and applied pharmacology (15-09-2018)
    “…DNA double-strand breaks (DSBs) are a highly toxic form of DNA damage produced by a number of carcinogens, drugs, and metabolic abnormalities. Involvement of…”
    Get full text
    Journal Article
  8. 8

    NAD+ metabolism controls growth inhibition by HIF1 in normoxia and determines differential sensitivity of normal and cancer cells by Luczak, Michal W., Krawic, Casey, Zhitkovich, Anatoly

    Published in Cell cycle (Georgetown, Tex.) (17-09-2021)
    “…The hypoxia-induced transcription factor HIF1 inhibits cell growth in normoxia through poorly understood mechanisms. A constitutive upregulation of hypoxia…”
    Get full text
    Journal Article
  9. 9

    Role of direct reactivity with metals in chemoprotection by N-acetylcysteine against chromium(VI), cadmium(II), and cobalt(II) by Luczak, Michal W, Zhitkovich, Anatoly

    Published in Free radical biology & medicine (01-12-2013)
    “…The antioxidant N-acetylcysteine (NAC) is widely used for the assessment of the role of reactive oxygen species (ROS) in various biological processes and…”
    Get full text
    Journal Article
  10. 10

    Atypical genotoxicity of carcinogenic nickel(II): Linkage to dNTP biosynthesis, DNA-incorporated rNMPs, and impaired repair of TOP1-DNA crosslinks by Krawic, Casey, Luczak, Michal W., Valiente, Sophia, Zhitkovich, Anatoly

    Published in The Journal of biological chemistry (01-12-2023)
    “…Cancer is a genetic disease requiring multiple mutations for its development. However, many carcinogens are DNA-unreactive and nonmutagenic and consequently…”
    Get full text
    Journal Article
  11. 11

    p53 Activation by Cr(VI): A Transcriptionally Limited Response Induced by ATR Kinase in S-Phase by Luczak, Michal W, Krawic, Casey, Zhitkovich, Anatoly

    Published in Toxicological sciences (01-11-2019)
    “…Cellular reduction of carcinogenic chromium(VI) causes several forms of Cr-DNA damage with different genotoxic properties. Chromate-treated cultured cells have…”
    Get full text
    Journal Article
  12. 12

    Monoubiquitinated H2B, a Main Chromatin Target of Formaldehyde, Is Important for S‐Phase Checkpoint Signaling and Genome Stability by Mishra, Sasmita, Krawic, Casey, Luczak, Michal W., Zhitkovich, Anatoly

    Published in Molecular carcinogenesis (01-12-2024)
    “…ABSTRACT Formaldehyde (FA) is a human carcinogen with ubiquitous environmental exposures and significant endogenous formation. Genotoxic activity of FA stems…”
    Get full text
    Journal Article
  13. 13

    Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma by LUCZAK, Michał W, ROSZAK, Andrzej, PAWLIK, Piotr, KEDZIA, Helena, KEDZIA, Witold, MALKOWSKA- WALCZAK, Blanka, LIANERI, Margarita, JAGODZINSKI, Paweł P

    Published in International journal of oncology (01-03-2012)
    “…The development of cervical cancer requires genetic and epigenetic factors which result in the persistence of a malignant phenotype. Cervical cancer exhibits…”
    Get full text
    Journal Article
  14. 14

    Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin by Rubis, Blazej, Luczak, Michal W., Krawic, Casey, Zhitkovich, Anatoly

    Published in Free radical biology & medicine (20-05-2019)
    “…Bleomycin is a redox-active drug with anticancer and other clinical applications. It is also frequently used as a tool in fundamental research on cellular…”
    Get full text
    Journal Article
  15. 15

    Nickel-induced HIF-1α promotes growth arrest and senescence in normal human cells but lacks toxic effects in transformed cells by Luczak, Michal W., Zhitkovich, Anatoly

    Published in Toxicology and applied pharmacology (15-09-2017)
    “…Nickel is a human carcinogen that acts as a hypoxia mimic by activating the transcription factor HIF-1α and hypoxia-like transcriptomic responses. Hypoxia and…”
    Get full text
    Journal Article
  16. 16

    Monitoring Cr Intermediates and Reactive Oxygen Species with Fluorescent Probes during Chromate Reduction by DeLoughery, Zachary, Luczak, Michal W, Zhitkovich, Anatoly

    Published in Chemical research in toxicology (19-05-2014)
    “…Cr­(VI) genotoxicity is caused by products of its reductive metabolism inside the cells. Reactive oxygen species (ROS) and Cr­(V,IV) intermediates are…”
    Get full text
    Journal Article
  17. 17

    Variation in Extracellular Detoxification Is a Link to Different Carcinogenicity among Chromates in Rodent and Human Lungs by Krawic, Casey, Luczak, Michal W, Zhitkovich, Anatoly

    Published in Chemical research in toxicology (18-09-2017)
    “…Inhalation of soluble chromium­(VI) is firmly linked with higher risks of lung cancer in humans. However, comparative studies in rats have found a high lung…”
    Get full text
    Journal Article
  18. 18

    DNA double-strand breaks by Cr(VI) are targeted to euchromatin and cause ATR-dependent phosphorylation of histone H2AX and its ubiquitination by DeLoughery, Zachary, Luczak, Michal W, Ortega-Atienza, Sara, Zhitkovich, Anatoly

    Published in Toxicological sciences (01-01-2015)
    “…Hexavalent chromium is a human respiratory carcinogen that undergoes intracellular activation in vivo primarily via reduction with ascorbate. Replication of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics by Luczak, Michal W, Green, Samantha E, Zhitkovich, Anatoly

    Published in Environmental health perspectives (01-01-2016)
    “…Carcinogenic hexavalent chromium [Cr(VI)] requires cellular reduction to generate DNA damage. Metabolism of Cr(VI) by its principal reducer ascorbate (Asc)…”
    Get full text
    Journal Article